agilon health inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is good.Its valuation is considered fairly valued, ranking 43 out of 74 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 29.63.In the medium term, the stock price is expected to trend up.Despite strong stock market performance and technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of agilon health inc is 5.55, ranking 67 out of 74 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 1.42B, representing a year-over-year decrease of 7.33%, while its net profit experienced a year-over-year decrease of 303.86%.
Key Metrics
The current valuation score of agilon health inc is 7.89, ranking 18 out of 74 in the Healthcare Providers & Services industry. Its current P/E ratio is -3.82, which is -91.09% below the recent high of -0.34 and -3210.04% above the recent low of -126.30.
The current earnings forecast score of agilon health inc is 6.00, ranking 63 out of 74 in the Healthcare Providers & Services industry. The average price target is 1.00, with a high of 2.00 and a low of 0.25.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of agilon health inc is 9.85, ranking 1 out of 74 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 103.37 and the support level at 41.61, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of agilon health inc is 7.00, ranking 37 out of 74 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 87.96%, representing a quarter-over-quarter decrease of 12.61%. The largest institutional shareholder is James Simons, holding a total of 149.04K shares, representing 0.89% of shares outstanding, with 186.41% increase in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of agilon health inc is 3.07, ranking 59 out of 74 in the Healthcare Providers & Services industry. The company's beta value is 2.63. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
